RxDoctor Payments Data

Robert Yong, MD

Anesthesiology · Boston, MANPI 1205002144

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $161,361 of the $231,421 with a category attached, or 69.7%. Medtronic accounts for 62.0% of it on its own, with 25 other manufacturers making up the rest. Among anesthesiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$231,421in general payments, 2019–2025

Across 625 payments — averaging $370.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$144K
  • Abbott$21K
  • Nevro Corp.$20K
  • Boston Scientific$13K
  • Biotronik NRO, Inc.$12K
  • AbbVie$10K
  • plus $12K from 20 others
$227,226in research payments, 2019–2025

Across 73 payments — averaging $3112.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$185K
  • Medtronic$20K
  • Abbott$16K
  • MML US, Inc.$7K

What the payments were for

  • Consulting fees$35,14915%
  • Speaking & faculty fees$161,36170%
  • Travel & lodging$13,8586%
  • Food & beverage$20,8909%
  • Education$1630%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$231,421 in reported general payments places this provider in the 95th percentile of 1,585 anesthesiology providers in Massachusetts.

See all anesthesiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$173,590
Medicare patients
535
Services billed
1,622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl36$23,553
NucyntaTapentadol Hcl17$20,043
BelbucaBuprenorphine Hcl19$17,932
Buprenorphine12$6,233
Gabapentin217$5,198
Lidocaine54$4,562
Oxycodone Hcl143$2,961
Baclofen96$2,927
Tizanidine Hcl107$2,129
Duloxetine Hcl45$1,885
Pregabalin80$1,733
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$863
Morphine Sulfate ErMorphine Sulfate19$803
Tramadol Hcl97$796
Methadone Hcl37$709

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →